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“After a while, if you are sufficiently bored or unemployed, you may want to read it from cover to 
cover.”  
― Leonard Cohen 
 
  
  
 
  
ABSTRACT 
 
Background: Irritable bowel syndrome (IBS), functional abdominal pain (FAP), and 
functional dyspepsia (FD) belong to the functional abdominal pain disorders, and are 
common in adolescents all over the world. Adolescents with IBS, FAP or FD often report 
anxiety, depression, school absenteeism, and a quality of life as low as children with 
inflammatory bowel diseases. The treatment effects from pharmacological or dietary 
treatments are unsatisfactory for this age group, while cognitive behavioral therapies (CBT) 
have shown some promising effects. However, CBT is rarely available as there are very few 
CBT-therapists trained in functional abdominal pain disorders. For adult IBS, exposure-based 
internet-delivered CBT (Internet-CBT) has been very successful, but this kind of treatment 
has neither been evaluated for adolescent IBS, nor adapted to the age group.  
Aims: The overall aim of this thesis was to develop an effective and easily accessible 
treatment for adolescents with functional abdominal pain disorders. Specific aims were to 
investigate: 
° The feasibility and potential efficacy of exposure-based Internet-CBT for adolescents 
with IBS, FAP or FD (Study I). 
° The efficacy of exposure-based Internet-CBT for adolescents with IBS (Study II). 
° Mechanisms of change in exposure-based Internet-CBT for adolescents with IBS 
(Study III). 
° The feasibility and potential efficacy of a tailored exposure-based Internet-CBT for 
adolescents with FAP or FD (Study IV). 
Methods: The feasibility and potential efficacy of the treatment were evaluated in an open 
pilot including adolescents (age 13-17) with IBS, FAP or FD (Study I). The efficacy of the 
treatment for adolescents with IBS was tested in a randomized controlled trial (RCT) with a 
wait-list control (Study II). Treatment mechanisms were investigated on data from the RCT, 
through analysis of change during treatment of two proposed mediators (perceived stress and 
avoidant behavior), and primary outcome (global gastrointestinal symptoms) (Study III). 
Lastly, the feasibility and potential efficacy of the treatment, when tailored specifically for 
functional abdominal pain and functional dyspepsia, were evaluated in an open pilot (Study 
IV). All trials had somatic symptoms as primary outcome, global gastrointestinal symptoms 
in Study I-III, and pain intensity in Study IV. Assessments were made at pretreatment, 
 posttreatment, and at 6-month follow-up (Study I-II and IV). In the RCT weekly assessments 
were included in the analyses (Study II). In Study IV, the follow-up assessments 6 months 
after treatment are still ongoing, and will therefore not be presented in the thesis. 
Results: In the first pilot treatment adherence was high, and the improvements were 
significant and moderately sized, with a stable treatment effect after 6 months (Study I). The 
RCT showed significant improvement on all relevant outcomes in favor of the treatment with 
small to moderate effect sizes, which were stable or significantly improved 6 months after 
treatment conclusion (Study II). The analysis of mediators showed that reduction in avoidant 
behavior, but not reduction in perceived stress, predicted improvement in gastrointestinal 
symptoms due to treatment (Study III). The open pilot for FAP and FD showed significant 
improvement with strong effect sizes on all relevant outcomes, from pretreatment to 
posttreatment (Study IV). 
Conclusion: Exposure-based Internet-CBT is a feasible and effective treatment for 
adolescent IBS. Feasibility and potential treatment effects may be increased with a tailored 
treatment for FAP and FD. Our results suggest that, it is by reducing avoidant behavior that 
gastrointestinal symptoms improve during exposure-based Internet-CBT, while a reduction in 
stress is not a necessary target in treatment. 
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1 INTRODUCTION 
About 90 % of all children that seek health-care for abdominal pain are deemed by their 
physician to have a functional gastrointestinal disorder (FGID) (1), that is, abdominal 
symptoms without somatic findings that explain the symptoms. Adolescents with FGIDs 
report a very low quality of life (2) and FGIDs in children and adolescents are associated with 
anxiety, depression and high school absenteeism (3). Symptoms from the abdomen are often 
unpleasant and cause much concern, as they could potentially be signs of serious illness. 
Hence, a variety of tests are often performed in the health-care to out-rule somatic causes (4). 
Moreover, this is a health-seeking population. In one study, adolescents with FGIDs used 20 
times more health care than healthy controls (5). In the US, the estimated cost for hospital 
admissions for children with FGIDs during 2009 were over 11.5 billion US dollars (6). It has 
not been possible to determine a single cause for the symptoms (7), and most treatments have 
proven insufficient or unavailable for children and adolescents. The suffering that many 
adolescents with FGIDs report, together with the high health care consumption, are strong 
arguments for the need for an effective treatment. In the present thesis, I will describe the 
development and evaluation of a cognitive behavioral psychological treatment (CBT) for 
adolescents with FGIDs. 
 
1.1 DIAGNOSTIC CRITERIA 
As FGID is characterized by a clustering of symptoms, and a lack of reproducible anatomical 
or biochemical findings that fully explain the symptoms, there was a need for a standardized 
symptom-based diagnostic criteria to establish a diagnosis (8). A diagnosis enables a 
definition of the population, which in turn allows for evaluations of, and comparisons 
between, interventions targeting the symptoms. In 1958, Apley and Naish introduced the 
diagnosis Recurrent abdominal pain (RAP) for children and adolescents with abdominal pain 
(9), defined as three or more episodes of abdominal pain occurring over at least three months, 
that caused some impairment of function. In 1999, the Rome II-criteria introduced specific 
diagnostic criteria for the pain-predominant FGIDs in children and adolescents, such as 
irritable bowel syndrome (IBS), functional abdominal pain (FAP) and functional dyspepsia 
(FD) (10). In 2006, the Rome III criteria replaced Rome II and defined the pain-predominant 
FGIDs as symptom-based diagnoses with weekly abdominal pain or discomfort over the last 
2 months not explained by somatic findings, located to the upper abdomen in FD, lower or 
middle abdomen in FAP, and related to a disturbed defecation pattern in IBS (11). In May 
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2016, the Rome Committee published new criteria, the Rome IV-criteria (12). All of the 
studies in the present thesis were conducted before that date, and are therefore based on the 
Rome III criteria. 
 
1.2 PREVALENCE 
FGIDs are common conditions all over the world as shown in prevalence studies from 
Europe, US, Australia, large parts of Asia and from South America (13). The changes in 
diagnostic criteria over the past 20 years have probably been one cause to the diversity in 
reported prevalence rates of FGIDs in children and adolescents, ranging from 12% to 29 % 
(14). A meta-analysis study, that pooled prevalence data from 58 studies, found a global 
prevalence of pediatric FGIDs of 13.5%, with IBS as the most frequent diagnosis (8.8%), 
while FD were reported to have a prevalence of 4.5%, and FAP (including functional 
abdominal pain syndrome) 4.4% (13). These figures are comparable to Swedish data on 
children and adolescents with FGID (15). 
 
1.3 PROGNOSIS 
Functional abdominal pain may persist over many years, also into adulthood (16). When 162 
children (age 8-16) diagnosed with RAP were interviewed 9 years later, 41% had a current 
FGID, most commonly IBS (17.6%) (17). Another prospective study showed an increased 
risk for life-time or current anxiety disorders among young adults with a child-history of 
RAP, compared to healthy controls, as well as a heightened risk for life-time or current FGID 
(18). The risk for anxiety disorders was even more pronounced for those with a current 
FGID, with social anxiety and generalized anxiety disorder being the most prevalent 
diagnoses (18). Comorbid anxiety and abdominal pain have also been associated with higher 
functional impairment (19). In conclusion, following a natural course, many children and 
adolescents with FGIDs will fully recover, but for a large group the abdominal problems are 
persistent and often concurrent with anxiety disorders and functional impairment.  
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1.4 ETIOLOGY 
The etiology of FGIDs is unclear, and the biopsychosocial model, first described by Engel 
(1977) is often used to explain the widths of factors shown to be associated with FGIDs (e.g., 
genetics, trauma, parental behavior, use of antibiotics, altered microflora, immune 
dysfunction/inflammation, life stress, diet, personality traits, coping strategies, social support) 
and how these factors act in concert to produce gastrointestinal (GI) symptoms (7). The broad 
acceptance of the biopsychosocial model for FGIDs offered the advantage of directing 
research towards including psychological and social variables (7), and away from an 
exclusively biomedical approach (20). However, the biopsychosocial model is too general to 
give any real guidance in treatment, and the vast amount of included variables may reflect the 
lack of knowledge about the causes, rather than the opposite.  
A model that has received increasing support through experimental research is the bi-
directional brain-gut model (20,21). The normal functioning of the brain-gut axis 
bidirectional communication is to continuously signal homeostatic information about the 
physiological condition of the body to the brain, and vice versa, signals that are usually 
completely imperceptible to the individual (22). However, numerous studies have shown 
changes in cortical modulation of pain and a heightened visceral sensitivity in adult IBS 
patients compared to healthy control (20). Dysfunction in the brain-gut axis communication 
might lower the threshold for visceral sensitivity, and allow physiological (non-noxious) 
stimuli to be detected by the individual. (20). This could explain how GI symptoms are 
exasperated in IBS and other FGIDs, and suggests a possible target for treatment. 
 
1.5 PHARMACOLOGICAL, DIETARY AND PROBIOTIC TREATMENTS 
There is a lack of trials evaluating pharmacological treatments for adolescents with FGIDs, 
hence the evidence for pharmacological treatment is weak (23,24). Anti-depressants are 
sometimes used in treatment of FGIDs in adolescents, but a recent Cochrane review 
concluded that the tricyclic anti-depressant Amitriptyline is the only anti-depressant that has 
been evaluated for FGIDs in the children and adolescents, and only in one high quality trial 
with no beneficial effects of Amitriptyline compared to placebo (25). Dietary changes are 
often suggested in outpatients clinics, but there are few trials published and thereby very little 
evidence for dietary interventions to be effective for pediatric FGID (26,27). The lack of 
effective pharmacological or dietary treatments has raised the interest for supplements with 
probiotics (live microorganisms). There is some support that the Lactobacillus LGG might 
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improve GI symptoms in children with IBS, but with few trials, the evidence for probiotics is 
still very limited (28). In summary, the evidence for pharmacological, dietary or probiotic 
treatments for pediatric FGID, is weak. 
 
1.6 PSYCHOLOGICAL TREATMENTS 
As the biopsychosocial model introduced psychological variables as important contributors to 
FGIDs, several psychological treatments trials have been conducted for adult IBS, a recent 
meta-analysis included 31 randomized controlled trials (29), whereas there have been 
considerably fewer studies conducted on psychological treatment for pediatric FGID, with 
eleven studies included in a recent review (27). 
Hypnotherapy, that includes relaxation and ego-strengthening suggestions in order to change 
intestinal hyper-sensitivity and relieve stress (30), has been shown to be quite effective for 
pediatric IBS and FAP in one large study (31), with long-lasting effects even after five years 
(32). However, the interpretation of the results of this study are somewhat hampered by the 
use of one single therapist, which makes the distinction between therapist effect and effect 
from the treatment as such, difficult. Besides this study, there are two small studies conducted 
on hypnotherapy for FGID, with mixed results (33,34).  
One randomized controlled trial used written self-disclosure as a treatment for RAP in 
adolescents, with some improvements after six months (35). In another trial a psychological 
treatment, described as “focusing on understanding and problem-solving”, was combined 
with physiotherapy (36). The combined treatment were compared to physiotherapy alone, 
with no significant differences detected between groups (36).  
In conclusion, the support for hypnotherapy as a treatment for pediatric FGIDs is limited, and 
the support for the other forms of psychological treatments, not including CBT, is almost 
non-existent. 
 
1.6.1 Cognitive behavior therapy 
CBT is the most evaluated psychological treatment for pediatric FGID (27,37). Cognitive 
behavior therapy for pediatric FGID has included relaxation and breathing techniques to 
relieve stress, coping strategies such as positive self-talk and distraction, and teaching parents 
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operant reinforcement to reduce pain behavior (38-40). In addition, some CBT protocols for 
abdominal pain also include exercises that target catastrophizing and negative thoughts (41-
44), increased physical activity (42,45,46) and interventions directed toward sleep hygiene 
and diet (45,46). To summarize, prior CBT for pediatric FGID have targeted some of the 
exogenous factors suggested to contribute to GI symptoms in the biopsychosocial model, 
especially stress (47). 
A Cochrane review on psychological treatments for pediatric FGID published in 2008 (48) 
concluded that CBT had promising effects, but that there was a need for larger and more-well 
designed studies. In 2010 Levy et al. published a large trial on 200 families that were 
randomized to either a 3-session CBT targeting parental behaviors, as well as teaching the 
children relaxation and coping skills, or a 3-session education about the GI systems anatomy 
and function, and information about diet guidelines (43). They reported three primary 
outcomes (pain intensity, global GI symptoms and functional disability) and saw a 
significantly larger improvement, as reported by the parents, in pain intensity and global GI 
symptoms immediately after treatment, in favor of CBT. However, the difference was not 
sustained at follow up. Furthermore, there was no difference between the groups on child-
reported primary outcomes (43). Van der Veek et al. (44) compared six sessions of CBT with 
six meetings with a pediatric gastroenterologist, including 104 children and adolescents with 
FAP. The CBT consisted of one standard module (relaxation and breathing exercises), and 3 
optional modules (targeting negative thought, maladaptive coping behavior and parents 
maladaptive coping) that the therapist selected. The pediatricians educated the family on the 
brain-gut axis, encouraged the child to continue normal activities despite symptoms, and 
prescribed medication. Both groups improved, with no significant difference between the 
groups (44). In summary, CBT showed promising effects in several early small studies with 
insufficient quality, but more recent large high-quality studies, have not confirmed the 
efficacy of CBT as a treatment for pediatric FGID. There are reasons to consider whether 
CBT for FGID could be enhanced. 
1.6.2 Exposure-based cognitive behavior therapy 
In adult IBS, exposure-based CBT has been very effective in improving global 
gastrointestinal symptoms, fear for symptoms and quality of life compared to wait-list control 
(49), a stress management intervention (50) and an intervention promoting behavioral 
activation without teaching exposure (51). The exposure-based CBT for IBS is partly based 
on the research demonstrating IBS-specific alterations in the brain-gut axis signaling. 
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Alterations such as, changes in pain modulation, and changes in brain regions associated with 
visceral sensations (21,52). These alterations may cause the IBS-patient to detect and 
experience more pain, and other symptoms from the GI tract (52). The term GI specific 
anxiety describes a pattern of fear and worry about GI symptoms (52), leading to behavioral 
avoidance of situations that might elicit symptoms (e.g. avoidance of food, certain social 
situations, or not having access to toilet facilities) (53). This pattern of behavioral avoidance 
has been associated with increased GI symptoms (54).  
The fear and avoidance model of maintenance and exacerbation of GI symptoms is closely 
related to the established two-factor theory, or fear and avoidance model, for anxiety 
disorders (55,56), that has also been described for chronic pain (57). In accordance with this 
theory, it has been suggested that the internal stimuli of visceral sensations from the 
gastrointestinal tract in an IBS-patient have become conditioned stimuli associated with 
anxiety and pain (22). Exposure to GI symptoms is a mean to decondition the association that 
visceral stimuli must be harmful, and instead add new learning circuits associating GI 
symptoms with non-threats. This is the target in exposure-based CBT for IBS. 
 
1.7 INTERNET-DELIVERED COGNITIVE BEHAVIOR THERAPY 
Internet-delivered CBT (Internet-CBT) is similar to traditional CBT in many respects, but 
also has some distinct features that may enhance availability and reduce barriers to treatment 
(58). All treatment content is delivered over the internet via text-files, audio-files and videos. 
Thus, the treatment can be delivered over any geographic distances, and all treatment content 
can be downloaded and saved for later review and rehearsal, yielding an opportunity for 
deeper learning. Furthermore, there is no need for scheduled meetings, as the participant can 
take part in the treatment at any hour convenient. This means that parents and adolescents 
don’t need to take time off from work or school to participate in the treatment. In addition, 
the therapist can deliver the treatment more effectively, as there is no need to go through all 
the content together with the participant. The therapist’s role is to support by encouraging the 
participant’s gradual progress in the treatment, as well as explaining and suggesting exercises 
when needed, all through text-messages sent through a dedicated web platform. Also, as all 
treatment content is delivered in the same mode and pace to all participants, the well-known 
risk of therapists drift is reduced (59). Consequently, Internet-CBT has the potential to be 
easily available, convenient and time-saving for both the participants and the therapists (58). 
Internet-CBT has been evaluated in over 100 trials for both psychiatric and somatic disorders 
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in adults with positive effects (60), as well as in children and adolescents with psychiatric or 
somatic disorders (58). Internet-CBT for adults has also shown promising results in terms of 
cost-effectiveness (61). 
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2 AIMS 
The aim of the thesis was to develop an effective and easily accessible treatment for 
adolescents with functional abdominal pain disorders. Specific aims for each study are 
presented below: 
 
2.1 STUDY I 
The aim of the first study was to evaluate the feasibility and potential efficacy for exposure-
based Internet-CBT for adolescents with IBS, FAP or FD. The hypothesis was that the 
treatment would be feasible and improve gastrointestinal symptoms and secondary outcomes, 
such as pain interference and fear of symptoms. 
 
2.2 STUDY II 
The aim of the second study was to evaluate the efficacy for exposure-based Internet-CBT for 
adolescents with IBS, compared to a wait-list control. The hypothesis was that Internet-CBT 
would lead to larger improvement than wait-list control in gastrointestinal symptoms, as well 
as secondary outcomes such as quality of life, avoidant behavior and fear of symptoms. 
 
2.3 STUDY III 
The aim of the third study was to investigate mechanisms of change in exposure-based 
Internet-CBT for adolescents with IBS, using data from Study II. The hypothesis was that 
Internet-CBT, targeting the mechanism of GI-specific anxiety, would lead to improvement in 
gastrointestinal symptoms through a prior reduction in avoidant behavior. 
 
2.4 STUDY IV 
The aim of the fourth study was to evaluate the feasibility and potential efficacy of an 
exposure-based Internet-CBT tailored for adolescents with FAP or FD. The hypothesis was 
that the credibility, adherence and satisfaction with treatment would be high, and that the 
treatment would lead to at least moderate improvements in pain intensity, as well as 
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secondary outcomes such as global gastrointestinal symptoms, quality of life, avoidant 
behavior and fear of symptoms. 
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3 METHODS 
 
3.1 DESIGN, ASSESSMENTS AND STATISTICS 
Study I was an open pilot without control group, including 29 participants who received 
Internet-CBT. Primary outcome was the global gastrointestinal symptoms measured with the 
adolescent-reported Gastrointestinal Symptoms Rating Scale (GSRS-IBS) (62). Assessments 
were made online at pretreatment, posttreatment and 6 months after treatment conclusion. 
Data were analyzed with dependent t-test, to estimate significance changes from pre- to 
posttreatment, and from pretreatment to 6-month follow up. Effect sizes were calculated with 
Cohen´s d, that is the standardized mean difference, with the limits for meaningful effects 
suggested as d=0.2 (small), d=0.5 (moderate) and d=0.8 (large) (63) , see Figure 1 for 
illustration of the effect sizes. 
 
 
 
Figure 1. Illustration of Cohen’s d effect-sizes 
 
Study II was a randomized controlled trial using wait-list as control, with 101 adolescents 
included, among them 47 received Internet-CBT while 54 were randomized to the wait-list. 
Cohen’s d	effect size - standardizedmean differences
Illustrations from rpsychologist.com
Small	effect size Moderate	effect size Large effect size
d =	0.2 d =	0.5 d =	0.8
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Primary outcome was the GSRS-IBS. Assessments were made on-line pretreatment, weekly 
during treatment, posttreatment, and for the treatment group also at 6-month follow up after 
treatment conclusion. Participants on the wait-list received the treatment after posttreatment 
assessment had been completed. Analyses were conducted on intent-to-treat basis with 
restricted maximum likelihood mixed models (MLMM) to estimate if there was a significant 
time*group interaction effect on change from pretreatment to posttreatment. Effect sizes were 
calculated with Cohen’s d. Parent-rated measures were clustered on the adolescent, since both 
parents provided data when possible. To estimate the change within the treatment-group, 
from pretreatment to follow-up, the MLMM were used with separate slopes from 
pretreatment to posttreatment, and from posttreatment to follow up, that were summed when 
investigating change from pretreatment to follow-up.  
Study III was a mediation analysis using data from the randomized controlled trial in Study 
II. Proposed mediators were avoidant behavior measured with the irritable bowel syndrome 
behavioral response questionnaire (IBS-BRQ) (54), and perceived stress measured with the 
Perceived Stress Scale (PSS-10)(64). The outcome was the GSRS-IBS, and the independent 
variable was change over time as a function of group. Assessments were made online 
pretreatment, posttreatment, and weekly during treatment on both mediators and outcome. 
Mediation was estimated with MLMM analyses estimating the paths connecting three 
variables, the X (independent variable), M (mediator variable), and Y (outcome variable). The 
X-Y path estimated the effect of group on the outcome, the X-M path estimated the effect of 
group on the mediators, while the M-Y path estimated the effect of the mediators on the 
outcome (65). The total mediated effect is calculated as the product of the estimates of the X-
M path and the M-Y path (66). See Figure 2 for illustration. Time-lagged analysis was made 
to confirm unidirectionality, that is, that the mediator changes before the outcome, and not as 
a consequence of a prior decrease in the outcome.  
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Figure 2. Mediational paths 
 
Study IV was an open pilot without control group (n=31), where all participants received the 
Internet-CBT. Assessments were made online at pretreatment and posttreatment. Treatment 
credibility and working alliance with the therapists were assessed at week 2 and week 4 
during treatment, respectively. Feasibility criteria were acceptable treatment adherence, 
acceptable treatment credibility, good working alliance with the therapist, satisfaction with 
the treatment, and potential efficacy. Primary outcome for potential efficacy was pain 
intensity as reported by the adolescents, measured with Faces pain rating scale-revised (67). 
Outcome data were analyzed using the dependent Student’s t-test and effect sizes were 
calculated with Cohen’s d.  
 
3.2 PARTICIPANTS 
All participants in Study I-IV were 13-17 years old, had been assessed by a physician to have 
a functional abdominal disorder, had one parent who was willing to participate in the 
treatment and had access to a computer and internet on a daily basis. In Study I all 
participants were living in Stockholm, were recruited through their treating physician, and 
had IBS (n=19), FAP (n=5) or FD (n=5). Studies II and IV included participants from all of 
Sweden. Advertising in national media and mail-lists to pediatricians were used to spread 
information about Study II, while only pediatricians were informed about Study I and IV. In 
Independent
variable,	X
(Treatment)
Dependent
variable,	Y
(GI-symptoms)
Mediator,	M
(Avoidant
behavior)
Mediator,	M
(Perceivedstress)
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Study II all included participants had IBS. In Study IV all participants had FAP (n=25) or FD 
(n=6). There were more girls than boys in all studies (62-76% girls), and the mean age was 
15 to 15.5 years. Duration of symptoms was four to five years. There were considerably more 
mothers than fathers who were the active parent in the treatment in all studies (72-90% 
mothers). 
 
3.3 THE TREATMENT 
The Internet-CBT protocols used in Study I-II and IV had the following common features, 
described below. 
The treatment was an adapted version of the exposure-based Internet-CBT for adults with 
IBS (49). The main target in treatment was exposure for abdominal symptoms by reducing 
avoidance and provoking symptoms. For instance, the participants were encouraged to eat 
food that they avoided for fear of symptoms (e.g. dairy-products), or take the bus to school 
instead of letting parents drive them to avoid stressful situations that could elicit symptoms, 
or to remain in school throughout the school day regardless of symptom level. Participants 
were encouraged to gradually increase the difficulty by combining multiple challenges, such 
as first drink large amounts of milk, then take the bus to school and stay there all day.  
The parents were mainly taught to reduce their attention to the adolescent’s symptoms, in 
order to reduce the risk for reinforcement of the adolescent’s symptom behavior, and to 
support their child to complete the treatment and carry out exposure exercises. Parents were 
also encouraged to routinely spend positive time with their adolescent in order to increase the 
focus on healthy behaviors, and promote a positive relationship to better be able to support 
their child in treatment.  
The treatment content was delivered in weekly modules and contained texts about how 
symptoms are maintained through the brain-gut signaling and how behavior and exposure to 
symptoms can affect the signals, supported by videos, audio-files and examples. In each 
module the participants answered questions about their own symptoms and behaviors related 
to the content of the module, and what exercises they planned to do during the week. The 
next module began with a follow-up of the previous week's exercises. The modules were 
unlocked sequentially as participants worked their way through the treatment.  
All treatment content was delivered over the internet. The adolescent and one parent were 
active in treatment while both parents were encouraged to take part in the content of the 
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parent treatment. The adolescent and the parent had separate login credentials. They received 
weekly therapist support from a clinical psychologist over the whole treatment course, 
through written messages within the platform. Therapist support consisted primarily of 
encouragement of any progress made in the treatment and support to find individual exposure 
exercises. The therapist also reminded participants to log in if they lagged behind, through 
platform-delivered mobile text-messages and through phone-calls.  
 
3.3.1 The Internet-CBT in Study I for adolescents with FGID 
In Study I we included adolescents with IBS, FAP and FD. They all received the same 
treatment, which consisted of 6 modules over 8 weeks, and the parents had 4 modules over 
the same time period. In this treatment the adolescents were taught mindfulness and 
acceptance exercises, in order to decrease reactivity caused by abdominal symptoms. The 
adolescents were also taught how to change problematic behavior around toilet-visits (i.e., 
frequent, urgent or prolonged visits), a common problem in the IBS-population. Those who 
did not have these kinds of behaviors were instructed to skip the exercises related to toilet 
behavior. Exposure-exercises were planned and conducted from module 4 to module 6. 
Modules 5 and 6 in the treatment were bi-weekly, to provide enough space in time for 
exposure exercises.  
 
3.3.2 The Internet-CBT in Study II for adolescents with IBS 
In Study II, to which only adolescents with IBS were included, the Internet-CBT was 
prolonged to ten weekly modules (during ten weeks) for the adolescents and five bi-weekly 
modules during 10 weeks for the parents. In the first modules (1-3) the adolescents mapped 
their IBS-specific behaviors in detail, were taught functional analysis, conducted a behavior 
experiment and planned exercises to reduce problematic toilet behavior. Exposure exercises 
were planned and executed from module 4 to module 10. The parents were taught basic 
positive parenting skills, in order to support their child to do the treatment. The parents could 
follow their child’s treatment through downloadable PDFs containing the text in the weekly 
module. For an overview of the treatment, see Figure 3. 
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Figure 3. The Internet-CBT in Study II 
 
3.3.3 The Internet-CBT in Study IV for adolescents with FAP or FD. 
To Study IV, the ten weeks long Internet-CBT used in Study II was further adapted. All 
examples involving IBS-specific behavior (i.e., behaviors related to the symptoms of 
defecation problems) were exchanged for examples better describing FAP or FD (i.e., 
behaviors related to abdominal pain, early satiety or nausea). All toilet behavior exercises 
were removed, and an exercise teaching neutral verbal labeling of symptoms (i.e., sensations, 
thoughts and feelings about symptoms) was added. The exposure exercises were planned and 
conducted during week 4 to week 10, as in Study II. The parents mapped own behavior when 
responding to their child’s symptoms and were encouraged to decrease behavior that could 
risk perpetuating abdominal symptoms. 
 
3.4 ETHICAL CONSIDERATIONS 
The rigorous recruitment procedure in the studies ensured that included participants had a 
functional abdominal pain diagnoses, and that a somatic cause for the abdominal problems 
was ruled out, as all participants in Study II and IV had the same basic medical investigation 
confirmed by a signed health-form from the treating physician. Other serious psychiatric or 
psychosocial conditions that required immediate intervention were ruled out before inclusion 
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through an on-line screening procedure as well as a clinical intake interview with a 
psychologist. The adolescents and parents (all legal guardians) signed an informed consent 
before inclusion, and the adolescents were specifically informed that they had the right to 
discontinue participation in the study whenever they wished, without having to specify a 
reason.  
The web-based platforms used for assessments and treatment were specifically developed for 
the purpose and used a double authentication procedure to login. All studies were approved 
by the Regional Ethics Review Board in Stockholm, Sweden 
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4 RESULTS 
 
4.1 STUDY I 
The primary outcome, global gastrointestinal symptoms, showed a significant improvement 
from pretreatment to posttreatment (mean difference -6.48; 95% CI [2.37, 10.58]) and from 
baseline to follow-up (mean difference -7.82; 95% CI [3.43, 12.21]). The effect size was 
moderate (within-group Cohen’s d = 0.50; 95% CI [0.16, 0.84]) and stable 6 months after 
treatment (d = 0.63; 95% CI [0.24, 1.02]). Treatment adherence was high, 22 out of 29 
adolescents completed the treatment. 
 
4.2 STUDY II 
There was a significant larger pre- to posttreatment change for the Internet-CBT group 
compared with the control group on the GSRS-IBS (B = -6.42, p =.006, effect size Cohen’s d 
= 0.45, 95% CI [0.12, 0.77]), and on almost all secondary outcomes,. After 6 months the 
results were stable or significantly improved.  
 
4.3 STUDY III 
We found that change in avoidant behavior, but not perceived stress, mediated the effect of 
exposure-based ICBT on GI symptoms. The decrease in avoidant behavior explained a large 
part (67%) of the total treatment effect. The control for a unidirectional relationship over time 
between avoidant behavior and GI symptoms, showed that a change in avoidant behavior 
predicted a later change in GI symptoms, but not the other way around. 
 
4.4 STUDY IV 
Adherence to treatment was acceptable with an average of 7.2 completed modules out of ten, 
including the six (19.4%) adolescents that dropped out from treatment. The adolescents 
reported the treatment to be credible, an overall satisfaction with the treatment, and good 
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alliance with their therapist. The improvement on the primary outcome, pain intensity, from 
pretreatment to posttreatment was significant with a large effect size (Cohen’s d = 0.96, p < 
.001, 95% CI [0.37, 1.56]). The adolescents also made significant and large improvements on 
secondary outcomes, such as gastrointestinal symptoms (d = 0.86, p < .001) and quality of 
life (d = 0.91, p < .001).  
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5 DISCUSSION 
 
The studies included in this thesis show that exposure-based Internet-CBT is feasible and 
potentially effective to reduce gastrointestinal symptoms, fear of symptoms and pain 
interference for adolescents with FGID (Study I), also when specifically tailored for FAP and 
FD (Study IV). The Internet-CBT was found to effectively reduce gastrointestinal symptoms, 
pain intensity, fear of symptoms, school absenteeism, and improve quality of life for 
adolescents with IBS, compared to a wait-list (Study II). The exposure-based Internet-CBT 
reduces avoidant behavior, a process which mediates a reduction in gastrointestinal 
symptoms (Study III). 
5.1 IS INTERNET-CBT FEASIBLE FOR ADOLESCENT FGID? 
To answer this question two studies were conducted, Study I that included adolescents with 
IBS, FAP or FD, and Study IV that included adolescents with FAP or FD only.  
The adolescents in Study I showed good adherence to the treatment, with low attrition rates, 
and significant and moderately-sized improvements from pretreatment to posttreatment in 
gastrointestinal symptoms, pain reactivity, and pain interference. The improvements were 
stable after 6 months. Hence, the treatment seemed to be feasible as well as potentially 
effective for adolescents with FGID. 
However, since the overall treatment effect in Study I, even though comparable to other 
studies on pediatric FGIDs, differed from the strong effects seen in adult studies, there was 
reason to review the treatment for all diagnoses, before we went on to conduct a randomized 
trial.  
In Study I the exposure exercises were limited to four weeks with two bi-weekly modules. 
The adolescents may have needed more time for exposure, and more support during the time 
for the exposure exercises. Furthermore, some adolescents had reported using the 
mindfulness and acceptance exercises as a means to immediately reduce GI symptoms, which 
was not the intention as it was contrary to the purpose of exposure, i.e., new learning in the 
presence of symptoms. Consequently, we decided to prolong the protocol to ten weekly 
sessions, emphasizing exposure and minimizing any other exercises. 
In addition, there were some observed, although not significant, differences between 
adolescents with IBS compared to adolescents with FAP/FD. Half of the adolescents with 
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FAP/FD dropped out of treatment (n = 5), and those who completed the treatment did not 
seem to benefit from the treatment to the same extent as those who had IBS. As only 10 of 
the included adolescents had FAP/FD, it was difficult to detect any significant differences in 
subgroup analyses. We suspected however, that the treatment might have been insufficiently 
adapted for FAP/FD, as it was derived from a treatment for adult IBS. Also, because IBS is 
the most common diagnosis among adolescents with FGID, most examples in the treatment 
described IBS-specific behavior. IBS-specific behavior are often the behaviors linked to the 
disturbed defecation pattern, which may evoke disgust and be something that other 
adolescents do not want to be associated with. Our clinical impression confirmed that this 
was the case for some participants with FAP/FD, which may have caused a lower adherence, 
and thereby a weaker treatment effect. Furthermore, the primary outcome, global 
gastrointestinal symptoms as measured by the GSRS-IBS, includes a wide range of IBS 
symptoms. As the adolescents with FAP/FD had a narrow range of gastrointestinal 
symptoms, there might have been a floor effect on the GSRS-IBS for this subgroup.  
Accordingly, a new prolonged treatment protocol was developed for adolescent FAP/FD 
leaving out all examples that referred only to IBS-symptoms, and including more examples 
related to FAP/FD symptoms and behavior. Furthermore, the primary outcome, pain 
intensity, was selected to better fit the group. With all these changes for FAP/FD, there was a 
need for a new feasibility study, to give the treatment a reasonable chance to show 
preliminary effects before it is compared in a large randomized trial (68), which led to Study 
IV. 
The adolescents in the Internet-CBT specifically adapted for FAP or FD, Study IV, showed 
good adherence, and reported high treatment credibility as well as satisfaction with the 
treatment. There were significant positive changes from pretreatment to posttreatment on the 
primary outcome, pain intensity, as well as on most secondary outcomes such as quality of 
life and global gastrointestinal symptoms, with large within-group effect sizes. The parents 
reported significant improvement with large effect sizes on their child’s gastrointestinal 
symptoms and quality of life, as well as a reduction in parental protectiveness and monitoring 
of their child’s symptoms. The treatment, when prolonged and adapted to FAP/FD seemed to 
be not only feasible for the group, but also potentially more effective than the prior treatment 
in Study I. 
The adherence in both Study I and Study IV was high compared to adherence reported in 
recent meta-analysis on adult Internet-CBT (69), and comparable to prior studies on 
adherence in adult Internet-CBT (70,71). Notably, the adolescents in Study IV rated a good 
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alliance with their therapist (a variable not assessed in Study I) despite the limited therapist 
contact, a phenomenon earlier reported in adult Internet-CBT (72) and Internet-CBT for 
adolescents with OCD (73). There are indications that a perceived alliance with the therapist 
can increase the motivation to continue treatment (74), but there is also evidence that good 
perceived alliance in itself does not increase the efficacy of internet-delivered treatments. 
(75). For the acceptability of the treatment, factors such as credibility, alliance and treatment 
satisfaction are probably important. In a treatment as demanding as an exposure treatment for 
pain and other unpleasant abdominal symptoms, the acceptance of the treatment and 
adherence to the treatment are important indicators that the participants perceive the treatment 
as feasible.  
There are many possible explanations for the large effect sizes in Study IV. The most obvious 
reason, beside the more extensive adaptation to the specific diagnoses, is the longer treatment 
duration. The treatment in this study was prolonged in the same manner as the treatment in 
Study II, which possibly affected the treatment effect. Also, the therapists were more 
experienced in delivering the treatment at the time for Study IV, and may have been more 
effective as therapists in Study IV, compared to Study I. Furthermore, several outcome 
measures were replaced or changed to better correspond with the symptoms that adolescents 
with FAP/FD report, yielding greater opportunity to capture a change in symptoms.  
 
5.1.1 Concluding remarks regarding feasibility of ICBT for FGID 
We cannot know for certain if it is the adaptation of the treatment content to the diagnoses, 
other above-mentioned changes made, or any possible differences between the samples, that 
provided larger effect sizes in Study IV, compared to Study I. However, it seems to be more 
effective to use a longer treatment format with weekly therapist support, and adapt examples 
and exercises to specific diagnoses. What we can conclude is that exposure-based Internet 
CBT is feasible for IBS, FAP and FD, and provides potentially positive effects on both the 
gastrointestinal symptoms, as well as secondary outcome measures, such as fear of symptoms 
and quality of life. The reported satisfaction with the treatment and good alliance with the 
therapist shows that the treatment can be delivered over the internet, and that it is acceptable 
to use exposure for abdominal pain and other GI-symptoms.  
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5.1 IS INTERNET-CBT EFFECTIVE FOR ADOLESCENT IBS? 
To investigate if the treatment could be more effective for adolescents IBS than the natural 
course of the diagnosis, we conducted Study II, a randomized controlled trial comparing the 
10-week long exposure-based Internet-CBT to a wait-list control. 
The adolescents in the treatment group in Study II had a significantly stronger improvement 
than the wait-list on the primary outcome, gastrointestinal symptoms as measured with the 
GSRS-IBS, as well as on most secondary outcomes, such as pain intensity and frequency, 
fear and worry about symptoms, school absenteeism and quality of life. The results were 
confirmed by the parents’ reports. At six-month follow-up, the treatment gains were either 
stable or further improved compared to posttreatment. Exposure-based Internet-CBT seems 
to be effective for adolescents with IBS compared to a wait-list control, with stable or 
improving long-term effects. 
As in Study I, the effect-sizes were lower than in the adult studies on exposure-based 
Internet-CBT for IBS (49,50,76). However, the adolescents reported a considerably lower 
level of gastrointestinal symptoms on the GSRS-IBS at baseline than adults with IBS have 
reported, with a difference between one half and one standard deviation. A low initial 
symptom level gives little room for improvement during treatment and hence, lower effect 
sizes. Despite the limited scope for improvement, the adolescents showed a significant 
improvement on the GSRS-IBS. 
Furthermore, although the treatment group improved more, the wait-list control group 
showed unexpectedly large improvement from pre- to posttreatment. The within-group 
improvement on the primary outcome was significant with a small effect size (Cohen’s 
d=0.33). Similar improvements were reported on avoidant behavior and perceived stress. This 
is in contrast to the study that used a wait-list control to examine the effect of exposure-based 
Internet-CBT for adults with IBS, where no improvement was seen for the participants on the 
wait-list (49). Prior research on adults on wait-lists have reported a recovery rate 
corresponding to Cohen’s d = 0.17 (77), which is substantially less than in our study. The size 
of the improvement on the wait-list in Study II is comparable to improvements seen in the 
active controls in studies on children with FAP (43) and chronic pain (78). This might mirror 
the natural course of the IBS-symptoms earlier mentioned. Even though most adolescents in 
our study reported several years of problems, indicating chronicity, some participants had 
only had their problems for a few months at baseline, increasing the likelihood of 
spontaneous recovery for that subgroup. The weekly assessments might have contributed to 
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some of the improvement in the wait-list group. Although it was a highly technical procedure, 
with online assessments and automated sms-reminders, it still might have served as a 
reminder of the clinical interview and the upcoming treatment, and thereby a kind of attention 
control. It is also possible that the questions in the weekly measurements gave some clues 
about how to act or not act in the presence of symptoms, or that assessment fatigue affected 
the responses. 
The relatively broad criteria for pediatric IBS per Rome III is a challenge when conducting 
treatment trials in this population. Because it might lead to inclusion of participants with quite 
low levels of symptoms which makes it difficult to obtain large effect sizes, as participants 
with diverging levels of symptoms introduce increased variance at baseline, and, at least for 
some, room for improvement is small. However, since everyone in the age group with IBS 
were included without restrictions on symptom level or functional disability, one might argue 
that this adds to the ecological validity. 
5.1.1  Concluding remarks regarding ICBT for adolescent IBS 
Despite the limited scope for improvement and the fact that the adolescents on the wait-list 
reported significantly improved gastrointestinal symptoms, the adolescents receiving the 
Internet-CBT reported a significantly larger improvement with a moderate effect-size on the 
primary outcome (d = 0.45), that was stable after 6 months. The steady improvement in 
gastrointestinal symptoms, along with the width of the improvements seen across almost all 
secondary outcome measures in favor of the treatment, indicates that exposure-based 
Internet-CBT is effective for adolescent IBS. 
 
5.2 DO AVOIDANT BEHAVIOR OR PERCEIVED STRESS MEDIATE 
CHANGE? 
 
The mediational analysis of two competing putative mediators, avoidant behavior and 
perceived stress, demonstrated that the exposure-based Internet-CBT leads to a reduction in 
avoidant behavior that mediates a reduction in gastrointestinal symptoms. Control for uni-
directionality showed that the opposite relationship did not apply, i.e., the change in 
gastrointestinal symptoms did not predict subsequent change in avoidance behavior. Thus, 
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the results confirm that the behavioral pattern, associated with GI anxiety and increased GI 
symptoms, is an important target in treatment.   
Exposure-based CBT for IBS encourages participants to provoke GI symptoms during 
exposure exercises. The assumption is that harmless visceral sensations have been 
conditioned as noxious stimuli, and that these stimuli are treated as a threat in the amygdala 
and initiates behavioral responses as well as physiological changes in the brain. These 
responses may result in increased fear of the noxious stimuli (79), in this case the GI 
symptoms. Through exposure, the patient gets in contact with the conditioned stimuli (CS), 
that elicit fear and worry (80). Exposure is the clinical application of extinction, a process of 
deconditioning of a learned conditioned pairing of an earlier neutral stimulus with something 
unpleasant. In a prior mediational analysis on adult IBS, a reduction in fear for symptoms 
predicted reduction in gastrointestinal symptoms due to exposure-based treatment, which 
indicates that the extinction process is targeted by the treatment (81). 
Robust findings from experimental research have led to the proposition that extinction is not 
a question of destruction of what has been learned, an unlearning, but rather that extinction 
gives the opportunity to new learning experiences in the presence of the CS (82). Thus, even 
if the CS after treatment is associated with more responses that inhibit the conditioned 
response (CR), the association with the original CR is still there (82). This leaves room for a 
relapse after exposure treatment, and in rodents a renewal of the CR has been observed after 
extinction, if the context changes (82). It has therefore been suggested that the CR is 
independent of context and therefore more readily available for retrieval than the extinction 
memory when context changes (82). Relapse of CR in another context has also been 
observed in humans after successful in vivo exposure (83). Repeated exposure in many 
different contexts has been suggested to prevent relapse (83). Through the analysis of 
repeated assessment of avoidant behavior, Study III demonstrated that a reduction during 
treatment in a broad range of IBS-specific behaviors, predicted a reduction in GI symptoms. 
A reduction in avoidance behavior indicates that the participants do the exposure exercises in 
many different contexts, and suggest an overall reduction of avoidance in everyday life, not 
only during planned exposure exercises. The further significant improvement in the treatment 
group on the IBS-BRQ six months after treatment completion, together with stable treatment 
gains on gastrointestinal symptoms (84), support the proposition that an overall reduction in 
avoidant behavior could prevent relapse after treatment conclusion. Through repeated 
exposure in changing contexts, the original association that visceral sensations from the 
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abdomen is a threat may have weakened, as many inhibiting associations have possibly been 
formed over time (85).  
Perceived stress decreased equally in both groups, and could therefore not function as a 
mediator of the difference between the groups in symptom level improvement. Importantly, 
the treatment group decreased significantly more in the primary outcome, GI symptoms, and 
this was found to be mediated by avoidance behavior and not a reduction in perceived stress. 
Thus, although the mediation analysis cannot rule out that reduced stress can potentially lead 
to reduced symptom, it can be concluded that it is not necessary to target stress in treatment 
for symptom improvement. 
 
5.2.1 Concluding remarks regarding mediators of change 
Study III demonstrated that a prior reduction in avoidant behavior predicts a reduction in 
gastrointestinal symptoms, due to treatment. A reduction in perceived stress is not related to 
the treatment, and did therefore not predict a later change in gastrointestinal symptoms, due to 
the treatment. Despite the common use of stress reducing components in other CBT-
treatments for pediatric FGID, such as relaxation or identification of stressors, this seems to 
be the first study within the field that has investigated a reduction in stress as a potential 
mediator. In this study we had weekly assessments of mediators and outcome during 
treatment, which gave the opportunity to do proper time-lagged analyses, that control for the 
occurrence of a change in the mediator before a change in the outcome. To the best of my 
knowledge, this has not been done before in the field of pediatric FGID, nor pediatric chronic 
pain. Weekly assessments require that the potential mediators are defined in advance, which 
increases the possibility that the potential mediators are theoretically based, and prevents 
exploratory post-hoc analyzes that could allow for random findings.  
 
5.3 LIMITATIONS 
 
There are some limitations that must be considered when interpreting the results from the 
studies included in the thesis. Study I and Study IV had an obvious limitation in the 
uncontrolled design to be able to draw conclusions on efficacy. An uncontrolled design 
cannot control for the natural course of FGID over time. Notably, most adolescents in Study 
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IV reported chronic symptoms, which made a spontaneous reduction during treatment less 
likely. The design is also somewhat of a limitation in Study II, because a wait-list could not 
control for attention, expectation of treatment and other unspecific effects from an active 
treatment. However, the unexpected improvement in the wait-list indicates that the wait-list 
somehow was affected, either by natural recovery, or that the weekly assessments acted as 
attention control. The mediators in Study III were chosen to investigate two competing 
theories on mechanisms of change in IBS-treatment, stress or the behavioral pattern related to 
GI anxiety. However, the outcome measures to assess the mediators tapped into different 
dimensions. The PSS does not measure stress behavior, but the perception of feelings of 
stress, while the IBS-BRQ do measure self-reported behavior, and not perception of feelings 
related to avoidance. There is a risk that these two dimensions are not entirely comparable. 
Notably, the PSS has been shown to predict health-related behavior, such as use of health 
care (64), and may be an adequate proxy to stress-related behavior. Also, the Internet-CBT 
investigated in these trials does not target a reduction in stress, but rather encourages an 
increase in stress, if participants use avoidance of stress as a strategy to control symptoms. If 
stress reduction had been an important part of the treatment, it is possible that a reduction in 
stress could prove to mediate a reduction in gastrointestinal symptoms. Furthermore, the 
adolescents included in the trials might not be totally representative of the adolescent 
population with FGIDs, as the thorough inclusion procedure probably demanded quite a high 
motivation to receive help, as well as supportive parents.  
 
5.4 IMPLICATIONS FOR FUTURE RESEARCH 
 
The findings in this thesis have some implications for future research. There is a need for 
replications with active control conditions. Although a waitlist is a valid control for pediatric 
FGID, as there is currently no standard medical treatment, a waitlist cannot control for the 
placebo-effect that is well-known to be quite effective in the population (86). A credible 
active control ensures that an effect from the exposure-based treatment is not solely the result 
of the participants’ expectations to improve from treatment, or attention and general support 
from a therapist. Although there are some indications that the treatment in our study may be 
more effective than treatments in previous large studies (43,44,78), given the width of 
positive change across multiple dimensions and the stable and even increasing improvements 
six months after treatment, we cannot be sure that exposure-based Internet-CBT is more 
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effective than other psychological treatments for adolescent IBS, before this has been 
demonstrated in studies with active controls. Evidently, a randomized controlled trial is also 
needed to investigate the efficacy of the treatment for adolescent FAP/FD, as this has not 
been done.   
There is also a need for further investigation into the mechanisms of change. The mediation 
study implicates that avoidant behavior is an important treatment target, and might also 
indicate that the mechanism of extinction of GI-anxiety is targeted in the treatment. However, 
this needs to be consistently demonstrated in replication studies (87). Avoidant behavior as a 
mediator would also need to be compared to other competing or complementing mediators, 
such as fear of symptoms, to better understand the mechanism of change in an exposure-
based treatment. If a reduction in avoidant behavior could predict a reduction in fear of 
symptoms, it would be further proof that the treatment acts through the extinction process, 
that is, exposure leads to opportunities for new learning, which in turn reduces fear of 
symptoms. If, on the other hand, fear predicts change in avoidant behavior, it could suggest 
that there rather is a cognitive process activated that reduces catastrophizing, and thereby 
reduces the anticipation anxiety. This would be important information to better optimize the 
treatment. In the treatment of pediatric FGID, it is also important to investigate the role of the 
parents, such as if a change in the parents’ protective behavior could predict a later change in 
their adolescent’s gastrointestinal symptoms, or if it is a prior reduction in the adolescent’s 
symptomatic level that predicts a reduction in parental protective behavior. Furthermore, 
stress reduction may be more important than the mediational analysis demonstrated, when 
also targeted in treatment.  
As one argument for internet-delivered treatments is the cost-effectiveness, which has been 
observed in adults (88), there is a need for studies investigating the cost-effectiveness for 
pediatric Internet-CBT. There are important differences in the treatment of children and 
adolescents compared to adults, such as more therapist-time per family and more detailed 
inclusion procedures to minimize risk, which may have impact on the treatment’s cost-
effectiveness.  
The scarce availability to effective treatments for pediatric FGIDs, makes it relevant to 
quickly disseminate a treatment that has proven efficacy in regular healthcare. That would 
require studies examining how such dissemination can be done while maintaining efficacy, 
and what processes are required for the treatment to be accepted as a viable treatment option 
in regular care. 
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6 CONCLUSION 
 
Exposure-based Internet-CBT is a feasible treatment for adolescent FGID. The treatment can 
effectively improve gastrointestinal symptoms, pain intensity and frequency, quality of life, 
avoidant behavior and fear and worry about symptoms in adolescent IBS, with stable or 
increasing long-term effects. It is also a feasible and potential effective treatment for FAP and 
FD, when specifically tailored for the diagnoses. Exposure-based Internet-CBT gives a 
reduction in avoidant behavior that mediates a subsequent change in gastrointestinal 
symptoms. Stress reduction does not seem to be a necessary target in treatment to improve 
GI-symptoms. The work in this thesis can contribute to increased access to effective 
treatment for the many adolescents who suffer from FGID. 
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